Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DAVA compared with BDTX: revenue, margins and what each company keeps, and the suppliers and customers both name
DAVA
Endava plc
Change
Mkt cap
Revenue
Revenue
BDTX
Black Diamond Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DAVA
Endava plc
vs
BDTX
Black Diamond Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
DAVA: latest quarter not drawable. BDTX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only DAVA
0
None
Shared
0
No disclosed counterparties: DAVA.
Only BDTX
3
GH
Guardant Health
supplier
—
Ivy Brain Tumor Center
unlisted
supplier
—
Servier Pharmaceuticals LLC (Servier)
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DAVA, solid
BDTX, dashed
DAVA
Endava plc
Change
1.66
▲
+6.41%
Mkt cap
$175.4M
Revenue
—
BDTX
Black Diamond Therapeutics, Inc.
Change
1.84
▲
+3.09%
Regular session
Nov 2 '26
Mkt cap
$102.3M
Revenue
$70M
Q1 FY25
vs
Compare
Regular session
Nov 2 '26
DAVA
Endava plc
vs
BDTX
Black Diamond Therapeutics, Inc.
1.66
▲
+6.41%
Price
1.84
▲
+3.09%
$175.4M
Mkt cap
$102.3M
—
Revenue
$70M
Q1 FY25
Change
Change
DAVA
1.66
▲
+6.41%
vs
BDTX
1.84
▲
+3.09%
Regular session
Nov 2 '26